K. Bae

发表

Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321.

J. Pouliot, I. Hsu, H. Sandler, 2008, International journal of radiation oncology, biology, physics.

Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.

H. Sandler, K. Bae, J. Efstathiou, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515.

Hak Choy, Jeffrey Bradley, Kyounghwa Bae, 2009, International journal of radiation oncology, biology, physics.

A descriptive analysis of postimplant dosimetric parameters from Radiation Therapy Oncology Group P0019.

H. Sandler, K. Bae, M. Kuettel, 2006, Brachytherapy.

Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610.

D. Grignon, K. Bae, J. Speight, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09.

Kyounghwa Bae, David A Bush, Anthony L Zietman, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Determinants of change in prostate-specic antigen over time and its association with recurrence after external beam radiation therapy for prostate cancer in

L. Kestin, H. Sandler, K. Bae, 2008 .

Potentiating effect of obacunone from Dictamnus dasycarpus on cytotoxicity of microtuble inhibitors, vincristine, vinblastine and taxol.

K. Bae, D. Sok, J. Lee, 2009, Planta medica.

Does timing of androgen deprivation influence radiation-induced toxicity? A secondary analysis of radiation therapy oncology group protocol 9413.

H. Sandler, K. Bae, D. Taussky, 2008, Urology.

Reply to S.G. Williams et al

H. Sandler, K. Bae, L. Souhami, 2009 .

Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117.

J. Fowler, R. Govindan, H. Choy, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results

Matthew J. Davis, R. Yelensky, D. Carbone, 2022, Nature Medicine.

A Prospective Phase I/II Study using Proton Beam Radiation to Deliver 82GyE to Men with Localized Prostate Cancer: Preliminary Results of ACR 0312

A. Zietman, K. Bae, W. Shipley, 2008 .

Reply to L. Collette et al and C.M. Tangen et al

H. Sandler, K. Bae, L. Souhami, 2009 .

Obesity and mortality in men with locally advanced prostate cancer

H. Sandler, K. Bae, J. Efstathiou, 2007, Cancer.

COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial.

D. Grignon, M. Hammond, H. Sandler, 2007, The Lancet. Oncology.

Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.

H. Choy, L. Gaspar, K. Bae, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of the duration of adjuvant hormonal therapy in patients with locally advanced prostate cancer treated with radiotherapy: a secondary analysis of RTOG 85-31.

H. Sandler, K. Bae, L. Souhami, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of biochemical failure classification on clinical outcome: A secondary analysis of Radiation Therapy Oncology Group 9202 and 9413

H. Sandler, K. Bae, W. Shipley, 2015, Cancer.

Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trials.

D. Grignon, H. Sandler, K. Bae, 2011, International journal of radiation oncology, biology, physics.

Impact of ultrahigh baseline PSA levels on biochemical and clinical outcomes in two Radiation Therapy Oncology Group prostate clinical trials.

D. Grignon, H. Sandler, B. Donnelly, 2011, International journal of radiation oncology, biology, physics.

Timing of salvage hormonal therapy in prostate cancer patients with unfavorable prognosis treated with radiotherapy: a secondary analysis of Radiation Therapy Oncology Group 85-31.

H. Sandler, K. Bae, L. Souhami, 2010, International journal of radiation oncology, biology, physics.

Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer.

H. Choy, R. Komaki, K. Bae, 2011, International journal of radiation oncology, biology, physics.

Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group.

Benjamin Movsas, Walter J Curran, Kyounghwa Bae, 2012, International journal of radiation oncology, biology, physics.

Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.

H. Choy, L. Gaspar, K. Bae, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06.

H. Sandler, K. Bae, J. Efstathiou, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of gender, partner status, and race on locoregional failure and overall survival in head and neck cancer patients in three radiation therapy oncology group trials.

A. Garden, K. Bae, T. Dilling, 2011, International journal of radiation oncology, biology, physics.

Impact of marital status and race on outcomes of patients enrolled in Radiation Therapy Oncology Group prostate cancer trials

K. Bae, B. Movsas, D. Bruner, 2012, Supportive Care in Cancer.

Cost Effectiveness of Modified Fractionation Radiotherapy versus Conventional Radiotherapy for Unresected Non–Small-Cell Lung Cancer Patients

H. Choy, R. Arriagada, J. Pignon, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer.

D. Grignon, H. Sandler, K. Bae, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study.

A. Markoe, H. Sandler, K. Bae, 2010, International journal of radiation oncology, biology, physics.

Acute and late toxicity after dose escalation to 82 GyE using conformal proton radiation for localized prostate cancer: initial report of American College of Radiology Phase II study 03-12.

Kyounghwa Bae, Jerry D. Slater, A. Zietman, 2011, International journal of radiation oncology, biology, physics.

MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.

Kyounghwa Bae, Alan Pollack, D. Grignon, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

JNJ-61186372 (JNJ-372), an EGFR-cMet bispecific antibody, in EGFR-driven advanced non-small cell lung cancer (NSCLC).

R. Govindan, Keunchil Park, E. Cho, 2019, Journal of Clinical Oncology.

Secondary Endpoints of a Phase II Randomized Trial (RTOG 0212): Impact of Different Total Doses and Schedules of Prophylactic Cranial Irradiation on Chronic Neurotoxicity and Quality of Life for Patients with Limited Disease Small-cell Lung Cancer

H. Choy, R. Komaki, K. Bae, 2009 .

The Influence of Gender, Race, and Marital Status on Survival in Lung Cancer Patients: Analysis of Radiation Therapy Oncology Group Trials

W. Curran, J. Coyne, H. Choy, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.

H. Sandler, K. Bae, J. Efstathiou, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.

H. Sandler, K. Bae, J. Efstathiou, 2008, European urology.

Patterns of missing mini mental status exam (MMSE) in radiation therapy oncology group (RTOG) brain cancer trials

K. Bae, B. Movsas, B. Corn, 2011, Journal of Neuro-Oncology.

Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: radiation therapy oncology group 0213.

Benjamin Movsas, Hak Choy, Kyounghwa Bae, 2011, Clinical lung cancer.

A phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer: Initial analysis of Radiation Therapy Oncology Group 0214.

H. Choy, L. Gaspar, K. Bae, 2009, Journal of Clinical Oncology.

Baseline serum testosterone in men treated with androgen deprivation therapy and radiotherapy for localized prostate cancer.

D. Grignon, H. Sandler, B. Donnelly, 2010, International journal of radiation oncology, biology, physics.